Go-to-Market Strategy for a Clinical Skincare Brand

Turning pharmaceutical credibility into market leadership for a clinical sunscreen brand entering India’s most trust-starved skincare category.

Overview

Lakulish Pharmaceuticals had a rare edge: pharma-grade credibility in a sunscreen market shaken by SPF controversy. The goal was to develop a comprehensive brand strategy, a go-to-market roadmap, SKU launch sequencing, and a marketing budget framework that converts lab credibility into category leadership, starting with a hero SKU on Amazon India.

Client

Lakulish Pharmaceuticals

Industry

Pharma / Skincare / D2C

Duration

72 Hours

Year

2026

Closing Thought

A great product without a strategy is just inventory. Every decision here, from platform sequencing to budget allocation, was built to make trust the brand’s most compounding asset.

01 Challenge

Position a new pharma-backed sunscreen brand in a crowded market where no player had yet claimed clinical transparency, while keeping launch budgets lean and unit economics viable.

02 Solution

We crafted a clinical trust-first brand strategy, phased the go-to-market entry across Amazon, Nykaa, and D2C, and built a detailed budget and SKU sequencing model backed by real unit economics.